| Calcyclin binding protein (CacyBP/SIP), a30kDa protein originally discovered inEhrlich ascites tumor cells as a S100A6(calcyclin) target by Filipek and Wojda and later onas a Siah-1interacting protein (SIP) by studying P53induced new degradation path ofβ-catenin ubiquitination. Siah-1Interacting Protein (SIP) was confirmed as a humanortholog’s CacyBP by sequence analysis. Hence, CalCyclin Binding Protein was formallynamed as CacyBP/SIP.CacyBP/SIP bound several calcium binding proteins of the S100family such asS100A1ã€S100A6ã€S100A12ã€S100B and S100P. S100proteins were the largest subgroupwithin the EF-hand Ca2+-binding protein family. Binding of Ca2+induced a conformationalchange in the S100molecule which in consequence increased its overall hydrophobicity andallowed for interaction with target proteins to play their own specific biological effect.CacyBP/SIP was present in the cytoplasm of unstimulated cultured neurons in which restingCa2+concentration which was known to be50nM. When Ca2+concentration was increasedto above300nM, the CacyBP/SIP was mainly apparent as a ring around the nucleus. Theseresults suggested that Ca2+concentration played an important role in CacyBP/SIP nucleartranslocation. whether CacyBP/SIP might enter nuclear to transfer signal as the thirdmessenger after binding of the S100proteins which were activated by binding of Ca2+. linvestigated it.Objective1. Effect on the nuclear translocation of CacyBP/SIP by the changes of Ca2+concentration in SW480colon cancer cells.2.The binding and the changes of binding capacity of S100A1ã€S100A6and CacyBP/SIP respectively before and after the nucleartranslocation in SW480colon cancer cells.Effect on the nuclear translocation of CacyBP/SIPby inhibiting the corresponding S100protein expression in SW480colon cancer cells.Methods1.The changes of CacyBP/SIP position and relative levels of the Ca2+concentration in SW480colon cancer cells after stimulation by ionomycin(0μmol/L,1μmol/L,2μmol/L,5μmol/L,10μmol/L)were detected by indirect immunofluorescence andlaser copolymerization focal.2.The changes of CacyBP/SIP position and relative levels of theCa2+concentration in SW480colon cancer cells after stimulation by ionomycin(5μmol/L)and BAPTA/AM(0μM,5μM,10μM,25μM)were evaluated by indirect immunofluorescenceand laser copolymerization focal.3.To exclude the influence of intracellular Ca2+concentration overload in this experiment, viability of cells was detected by MTT assay,meanwhile, Annexin V/PI assay was used to detected the apoptosis in colon cancer cells.4.The binding and the changes of binding capacity of S100A1ã€S100A6and CacyBP/SIPrespectively were detected by co-immunoprecipitation before and after the nucleartranslocation by increasing Ca2+concentration.5.l designed three S100A6siRNA andselected the best group of siRNA silencing effect to transfect the SW480colon cancer cellsby Real-Time PCR and Western blot. It was detected by immunofluorescence that the effecton the nuclear translocation of CacyBP/SIP by inhibiting S100A6expression in SW480coloncancer cells.Results1.CacyBP/SIP was mainly located in the cytoplasm of colon cancer cells in the absenceof stimulation. CacyBP/SIP translocated into nucleus after stimulation by ionomycin, and thenuclear translocation of CacyBP/SIP was the most obvious after stimulation byionomycin(5μmol/L). CacyBP/SIP redistributed in the cytoplasm and nucleus with the furtherincreasing of ionomycin concentration(10μmol/L). The intracellular Ca2+concentration wasgradually increased after stimulation by ionomycin,and was the highest after stimulation by ionomycin(5μmol/L). After that,with the further increasing of ionomycin concentration,Ca2+concentration tended to smooth(P=0.000). The results suggested that CacyBP/SIPtranslocated into nucleus with the increasing of Ca2+concentration and redistributed in thecytoplasm and nucleus with the further increasing of Ca2+concentration.2. With the increasing of BAPTA/AM concentration gradually,CacyBP/SIP translocatedfrom the nucleus to cytoplasm. With the increasing of BAPTA/AM concentration gradually,the intracellular Ca2+concentration reduce at the same time(P=0.000). The results suggestedthat CacyBP/SIP translocated from the nucleus to cytoplasm with the reducing of Ca2+concentration.3. MTT assay showed that proportion of cells viability between the treated group anduntreated group was not statistically significant(P=0.985). Annexin V/PI assay also found noobvious early apoptotic(P=0.168). The results suggested that the overloading of intracellularCa2+concentration had no effect on the experimental results and the experimental resultswere accurate and reliable.4. The changes of binding capacity of S100A1ã€S100A6and CacyBP/SIP respectivelywas apparent different before and after the nuclear translocation. The binding capacity ofS100A1and CacyBP/SIP was very little and the changes of binding capacity was notstatistically significant before and after the nuclear translocation(P>0.05).The resultssuggested that S100A1may have no or little effect on the nuclear translocation ofCacyBP/SIP. However, the binding capacity of S100A6and CacyBP/SIP was significantlyincreased(P<0.05),and was significantly higher than the combined amount of S100A1beforeand after the nuclear translocation(P<0.05). These results suggested that S100A6may play animportant role in CacyBP/SIP nuclear translocation.5. The Real-Time PCR and Western blot test results suggested that the group ofsiRNA-S100A6-2was the best group of siRNA silencing effect and the inhibition rates were87.9%and85.0%respectively, so the group of siRNA-S100A6-2was used to transfect the SW480colon cancer cells.The nuclear translocation of CacyBP/SIP was significantlyinhibited after stimulation by ionomycin(5μmol/L), locateing in the cytoplasm and nucleusof colon cancer cells. CacyBP/SIP did not translocate to the nucleus perfectly.These resultsfurther suggested that S100A6played an important role in CacyBP/SIP nucleartranslocation.Conclusions1. CacyBP/SIP translocated into nucleus with the increasing of Ca2+concentration, andredistributed in the cytoplasm and nucleus with the further increasing of Ca2+concentration inSW480colon cancer cells. With the reducing of Ca2+concentration, CacyBP/SIP translocatedfrom the nucleus to cytoplasm. In a word, CacyBP/SIP could translocate into and out of thenucleus with the changing of intracellular Ca2+concentration.2. S100A1and S100A6could combine CacyBP/SIP before and after the nucleartranslocation in SW480colon cancer cells. The binding capacity of S100A1and CacyBP/SIPwas very little and the changes of binding capacity was not statistically significant before andafter the nuclear translocation. These results suggested that the influence of S100A1onCa2+-mediated nuclear translocation of CacyBP/SIP was may little or inexistence. However,the binding capacity of S100A6and CacyBP/SIP was significantly increased.CacyBP/SIPnuclear translocation was significantly inhibited by reducing S100A6expression at the sametime.These results suggested that the Ca2+-mediated combination of S100A6and CacyBP/SIPplayed an important role in CacyBP/SIP nuclear translocation in SW480colon cancer cells. |